Clinical trial
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric…
NCT00252161 · Haruhiko Fukuda, Other · Completed
Key facts
| NCT number | NCT00252161 |
|---|---|
| Title | A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer |
| Official title | Randomized Phase III Trial of Surgery Plus Neoadjuvant TS-1 and Cisplatin Compared With Surgery Alone for Type 4 and Large Type 3 Gastric Cancer: Japan Clinical Oncology Group Study (JCOG 0501) |
| Lead sponsor | Haruhiko Fukuda, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Neoplasm |
| Intervention type | Drug, Procedure |
| Interventions | Gastrectomy with more than D2 dissection, Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy |
| Enrollment | 316 |
| Start date | Nov 1, 2005 |
| Primary completion | Apr 1, 2015 |
| Completion | Apr 1, 2015 |
| First posted | Nov 11, 2005 |
| Last update posted | Sep 22, 2016 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: